| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,006 | 7,443 | 7,769 | 7,422 | | Cost of Revenue | 6,147 | 5,806 | 6,123 | 6,116 | | | Gross Profit | 1,859 | 1,637 | 1,646 | 1,306 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 2,174 | 2,268 | 2,351 | 2,118 | | Non Recurring | 2,686 |
-
|
-
| 194 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,001) | (631) | (705) | (1,006) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 2,866 | (2,686) |
-
| (75) | | Earnings Before Interest And Taxes | (1,577) | (3,317) | (705) | (1,081) | | Interest Expense | (845) | 437 | 408 | 172 | | Income Before Tax | (732) | (3,754) | (1,113) | (1,253) | | Income Tax Expense | 50 | 51 | 41 | 1,072 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (782) | (3,805) | (1,154) | (2,325) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| 1,021 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (782) | (3,805) | (1,154) | (1,304) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($782) | ($3,805) | ($1,154) | ($1,304) |
|
0.51% Nasdaq 
Income Statement
